Glucokinase mutations in young children with hyperglycemia

Diabetes/Metabolism Research and Reviews

Volumn 22, Issue 5, 2006, Pages 348-355

  Codner, Ethel ^a   Deng, Liyong ^b   Pérez Bravo, Francisco ^c   Romän, Rossana ^a,d   Lanzano, Patricia ^b   Cassorla, Fernando ^a   Chung, Wendy K ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF CHILE   (Chile)

^d HOSPITAL SAN BORJA ARRIARÁN   (Chile)

Author keywords

Diabetes; Glucokinase; Incidental hyperglycemia; MODY

Indexed keywords

ARGININE; ASPARTIC ACID; GLIBENCLAMIDE; GLUCOKINASE; GLUCOSE; GLUTAMINE; GLYCINE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; ISOPHANE INSULIN; SULFONYLUREA DERIVATIVE; TRYPTOPHAN;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHILD; CLINICAL ARTICLE; DIABETOGENESIS; DIET RESTRICTION; DIET THERAPY; DISEASE SEVERITY; DRUG WITHDRAWAL; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LOW DRUG DOSE; MALE; MATURITY ONSET DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROGNOSIS;

BASE SEQUENCE; BIRTH WEIGHT; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; FEMALE; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; HYPERGLYCEMIA; MALE; MUTATION; PEDIGREE;

EID: 33748994550     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.622     Document Type: Article

References (27)

1. Bhisitkul DM, Morrow AL, Vinik AI, Shults J, Layland JC, Rohn R. Prevalence of stress hyperglycemia among patients attending a pediatric emergency department. J Pediatr 1994; 124: 547-551, DOI: 8151468.
2. Knip M. Natural course of preclinical type 1 diabetes. Horm Res 2002; 57(Suppl. 1): 6-11, DOI: 11979015.
3. Tattersall RB. Mild familial diabetes with dominant inheritance. Q J Med 1974; 43: 339-357, DOI: 4212169.
4. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345: 971-980, DOI: 11575290.
5. Frayling TM, Evans JC, Bulman MP, et al. β-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 2001; 50(Suppl. 1): S94-100, DOI: 11272211.
6. Massa O, Meschi F, Cuesta-Munoz A, et al. High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI. Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetes (SIEDP). Diabetologia 2001; 44: 898-905, DOI: 11508276.
7. Ehtisham S, Hattersley AT, Dunger DB, Barrett TG. First UK survey of paediatric type 2 diabetes and MODY. Arch Dis Child 2004; 89: 526-529, DOI: 15155395.
8. Barrio R, Bellanne-Chantelot C, Moreno JC, et al. Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families. J Clin Endocrinol Metab 2002; 87: 2532-2539, DOI: 12050210.
9. Gloyn AL. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum Mutat 2003; 22: 353-362, DOI: 14517946.
10. Gloyn AL, Noordam K, Willemsen MA, et al. insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. Diabetes 2003; 52: 2433-2440, DOI: 12941786.
11. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002; 109: 45-60, DOI: 11773541.
12. Youlton R, Valenzuela C. Growth patterns in height and weight in children aged 0 to 17 years and cranial circumference in children aged 0 to 2 years from medium-high and high socioeconomic status in Santiago. Comparison with growth in children from medium-low and low status in the Northern area of Santiago. Rev Chil Pediatr 1990; Spec No: 61: 1-22, DOI: 2091069.
13. Juez G. Intrauterine growth curve for the appropriate diagnosis of intrauterine growth retardation. Rev Med Chil 1989; 117: 1311, DOI: 2519812.
14. Bazaes RA, Salazar TE, Pittaluga E, et al. Glucose and lipid metabolism in small for gestational age infants at 48 hours of age. Pediatrics 2003; 111: 804-809, DOI: 12671116.
15. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27(Suppl. 1): S5-S10, DOI: 14693921.
16. Perez-Bravo F, Oyarzun A, Carrasco E, Albala C, Dorman JS, Santos JL. Duration of breast feeding and bovine serum albumin antibody levels in type 1 diabetes: a case-control study. Pediatr Diabetes 2003; 4: 157-161, DOI: 14710775.
17. Pearson ER, Velho G, Clark P, et al. β-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. Diabetes 2001; 50(Suppl. 1): S101-S107, DOI: 11272165.
18. Stride A, Vaxillaire M, Tuomi T, et al. The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 2002; 45: 427-435, DOI: 11914749.
19. Screening for diabetes. Diabetes Care 2002; 25: 21S-224, DOI:.
20. Lorini R, Alibrandi A, Vitali L, et al. Risk of type 1 diabetes development in children with incidental hyperglycemia: a multicenter Italian study. Diabetes Care 2001; 24: 1210-1216, DOI: 11423504.
21. Owen K, Hattersley AT. Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Best Pract Res Clin Endocrinol Metab 2001; 15: 309-323, DOI: 11554773.
22. Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 1998; 19: 268-270, DOI: 9662401.
23. Spyer G, Hattersley AT, Sykes JE, Sturley RH, MacLeod KM. Influence of maternal and fetal glucokinase mutations in gestational diabetes. Am J Obstet Gynecol 2001; 185: 240-241, DOI: 11483936.
24. Levy-Marchal C, Jaquet D. Long-term metabolic consequences of being born small for gestational age. Pediatr Diabetes 2004; 5: 147-153, DOI: 15450010.
25. Ellard S, Beards F, Allen LI, et al. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia 2000; 43: 250-253, DOI: 10753050.
26. Mantovani V, Salardi S, Cerreta V, et al. Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young. Hum Mutat 2003; 22: 338, DOI: 12955723.
27. Weng J, Ekelund M, Lehto M, et al. Screening for MODY mutations, GAD antibodies, and type 1 diabetes-associated HLA genotypes in women with gestational diabetes mellitus. Diabetes Care 2002; 25: 68-71, DOI: 11772903.